Building windows

July, 2013 Newsletters

Intellectual Property and Patent Litigation Group After District Court Invalidates Pharmaceutical Product Patent Based on Clinical Trials, Federal Circuit Reverses Because Clinical Trial Was Not Public

After District Court Invalidates Pharmaceutical Product Patent Based on Clinical Trials, Federal Circuit Reverses Because Clinical Trial Was Not Public   Sunovion Pharmaceuticals, Inc. (“Sunovion”) and Dey L.P., Dey, Inc., and Mylan, Inc. (collectively, “Dey”) develop pharmaceutical products to treat lung disease. Sunovion filed a patent application, followed by an application to test its products […]